Literature DB >> 4712630

Dantrolene, a direct acting skeletal muscle relaxant.

K O Ellis, A W Castellion, L J Honkomp, F L Wessels, J E Carpenter, R P Halliday.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4712630     DOI： 10.1002/jps.2600620619

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  19 in total

1.  Effect of dantrolene sodium upon the activity of the hind leg muscle of the cat with local tetanus.

Authors:  K Takano
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000

2.  Dantrolene prevents arrhythmogenic Ca2+ release in heart failure.

Authors:  Joshua T Maxwell; Timothy L Domeier; Lothar A Blatter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-16       Impact factor: 4.733

Review 3.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

4.  Effect of chronic dantrolene sodium administration on striatal muscles of the rat. A morphometric study.

Authors:  R W De Potter; J De Reuck; W De Coster; H Vander Eecken
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

5.  Quantitative grip strength assessment as a means of evaluating muscle relaxation in mice.

Authors:  M E Nevins; S A Nash; P M Beardsley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 6.  Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546

7.  The action of dantrolene sodium on individual fast and slow motor units of the rat anaesthetized with urethane.

Authors:  G C Leslie; N J Part
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

8.  Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle.

Authors:  B A Britt; E Scott; W Frodis; M J Clements; L Endrenyi
Journal:  Can Anaesth Soc J       Date:  1984-03

Review 9.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

10.  The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide.

Authors:  W M Behan; A M Bakheit; P O Behan; I A More
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.